Australian Scientists Identify Enzyme With Role In Heart Attack Damage
This article was originally published in PharmAsia News
Australian researchers report that a nasal enzyme has a role in causing damage during a heart attack. Working at the ARC Centre of Excellence for Free Radical Chemistry and Biotechnology, the scientists said the acid-containing enzyme is automatically dumped onto bacteria after white cells detect their presence. The enzyme in turn produces an acidic bleach, also used as a common way to get rid of bacteria. Under inflammatory conditions such as heart attack, however, the enzyme is dumped in the wrong place. Scientists also have identified antioxidant nitroxides effective in preventing the enzyme from producing its acid. (Click here for more
You may also be interested in...
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.
In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.
In the age of coronavirus, human factors professionals are doing their best to find their way through the pandemic by putting unique twists on usability testing to see what works and what doesn’t in the new reality. That’s the topic of this week’s podcast.